Axonics, Medtronic
Axonics defeats Medtronic lawsuit in spine-stimulation patent trial
Medical device maker Axonics has convinced a jury in California federal court that it did not violate rival Medtronic's patent rights in nerve-stimulation technology.
Jury rules for Axonics in Medtronic’s long-running neuromodulation patent lawsuit
A federal jury in California has found that Axonics’ neurostimulators and electric leads for treating incontinence do not run afoul of three patents held by the company’s main rival, Medt | The case is one of several intellectual property disputes between the medtech giant and Axonics—which is currently waiting to become a subsidiary of Boston Scientific.
Jury sides with Axonics in Medtronic patent dispute
Meanwhile, Boston Scientific is still waiting for antitrust regulators to conclude their review of its proposal to buy Axonics, which was announced in January.
Axonics did not infringe Medtronic’s patents, jury rules
California medical device company Axonics has won its patent infringement trial after Medtronic alleged the company had copied three elements of its sacral neuromodulation technology. The lawsuit ...
Axonics gains after win in trial in patent dispute with Medtronic
Axonics Inc. (NASDAQ:AXNX) rose 1.5% in after hours trading after a jury voted in is favor in a patent dispute with Medtronic (MDT). Medtronic (MDT) was seeking $150 million in a patent dispute with Axonics (AXNX),
Medscape3d
New Pharmacologic and Minimally Invasive Therapies for the Overactive Bladder
Before the approval of sacral nerve stimulation (SNS), urologists had ... With the introduction of SNS (Medtronic, Inc), a new surgical technique developed by urologists for urologists is now ...
GlobalData on MSN4mon
Medtronic bags FDA approval for Inceptiv spinal cord stimulator
Medtronic secured approval from the US Food and Drug Administration (FDA) for its closed-loop spinal cord stimulation ...
FierceBiotech3d
Awaiting FDA review, Medtronic details study of adaptive neurostimulation in Parkinson’s disease
Medtronic is offering a peek into its ongoing, at-home trial of people with Parkinson’s disease being treated with adaptive deep brain stimulation, a technology that’s currently under review ...
Genesis urogynecologist recognized by medical device company for treatment usage
the completion of Medtronic education courses and successful implantation of a minimum of 500 patients with the InterStim ...
Seeking Alpha27d
Medtronic: Is The Company Back?
Medtronic faced challenges, including poor focus, lack of innovation, and COVID-19 impact, leading to share price stagnation since 2018. Despite recent improvements in performance, Medtronic ...
CNN1y
Medtronic Plc
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the ...
Wall Street Journal4mon
Medtronic PLC
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...